Browse by Person

View wider browse menu Up a level
[feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 3.

Hardy-Werbin, M., Rocha, P., Arpi, O. et al. (13 more authors) (2019) Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer. OncoImmunology. ISSN 2162-4011

Hardy-Werbin, M., Arpi, O., Taus, A. et al. (10 more authors) (2018) Assessment of neuronal autoantibodies in patients with small cell lung cancer treated with chemotherapy with or without ipilimumab. OncoImmunology, 7 (2). e1395125. ISSN 2162-402X

Arriola, E., Wheater, M., Galea, I. et al. (13 more authors) (2016) Outcome and biomarker analysis from a multi-centre phase 2 study of ipilimumab in combination with carboplatin and etoposide (ICE) as first line therapy for extensive stage small cell lung cancer. Journal of Thoracic Oncology, 11 (9). pp. 1511-1521. ISSN 1556-0864

This list was generated on Sat Sep 12 21:55:52 2020 BST.